Navigation Links
QRxPharma Doses First Patients in Phase III Clinical Trial Program for its 'Dual Opioid' Pain Therapy
Date:11/26/2007

that synergistically combines sub-analgesic doses of oxycodone and morphine. Several clinical trials to date have shown that this unique, dual-opioid combination can achieve equal or better analgesic pain relief at materially lower doses than the active opioid comparator while simultaneously reducing side effects (eg: less nausea, vomiting, respiratory depression, constipation and sedation).

Forward Looking Statements

This press release contains forward-looking statements that involve risks and uncertainties. The forward-looking statements contained herein represent the judgment of QRxPharma as of the date of this release. These forward-looking statements are not guarantees for future performance. Actual results could differ materially from those currently anticipated to due to a number of factors including risks relating to the stage of products under development; uncertainties relating to clinical trials; dependence on third parties; future capital needs; and risks relating to the commercialization of the Company's proposed products.

About QRxPharma

QRxPharma (ASX: QRX) is a clinical-stage specialty pharmaceutical company focused on the development and commercialization of new treatments for pain management and central nervous system (CNS) disorders. Based on a development strategy which focuses on enhancing and expanding the clinical utility of currently marketed compounds, the Company's product portfolio includes both late and early stage clinical drug candidates with the potential for reduced risk, abbreviated development paths, improved safety and patient outcomes, and greater market value for direct commercialization in the US as well as potential for strategic partnerships abroad. QRxPharma's lead compound, Q8003IR, began its Phase III development program in November 2007. The Company's preclinical and clinical pipeline includes other technologies in the fields of pain management, neurodegenerative disease and venomics. For m
'/>"/>

SOURCE QRxPharma
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Peregrine Pharmaceuticals Doses First Patient in Cotara(R) Phase II Brain Cancer Trial In India
2. Opko Health Doses First Patient in Phase 3 COBALT Trial of Bevasiranib for the Treatment of AMD
3. Peregrine Pharmaceuticals Doses First Patient in Clinical Trial of Bavituximab in HCV Patients Co-Infected With HIV
4. Reclast(R) Receives US FDA Approval as First and Only Once-Yearly Treatment for Women With Postmenopausal Osteoporosis
5. Sixty-One Percent of Newly Diagnosed Parkinsons Disease Patients Do Not Receive Any Drug Treatment in the First Year of Diagnosis
6. Xenomics Announces Implementation of its First Diagnostic Test for Acute Myeloid Leukemia Into Clinical Practice
7. GlaxoSmithKline Receives New HHS Order for H5N1 Bulk Antigen. First North American Clinical Trials with GSKs Candidate Pre-pandemic Flu Vaccine to Start.
8. Video: Landmark Study in The Lancet: Patients Treated With Betaseron(R) After First MS Attack Experienced Significant Delay in MS Progression
9. Tainted Chinese Food Ingredients First Discovered in 2005
10. First Patient Enrolled in Europe in Ovature Phase III Ovarian Cancer Trial
11. Protalix BioTherapeutics Treats First Patient in Phase III Clinical Trial of prGCD
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/27/2015)... 27, 2015 According to a new market ... Seating, Universal, Standing, Bariatric ), Material (Nylon, Padded, Canvas), Usage Type ... published by MarketsandMarkets, the Medical Lifting Sling Market is poised to ... 2015, at a CAGR of 11.4 % from 2015 to 2020. ... rket data T ables and 65 ...
(Date:8/27/2015)... Pa. , Aug. 27, 2015  Now that ... the Da Vinci S™ surgical robot, hospitals with robotic ... plans. They also need to see where they stand ... on the right patients? Have they adopted best practices ... surgery program in the future? ECRI Institute, ...
(Date:8/27/2015)... 2015   Proxsys Rx, the nation,s ... expanding its population health management services with ... care program for hospitals and health systems. ... with technology systems and pharmacy support services ... been mandated by Center for Medicare and ...
Breaking Medicine Technology:Medical Lifting Sling Market Worth USD 706.0 Million by 2020 2Medical Lifting Sling Market Worth USD 706.0 Million by 2020 3Medical Lifting Sling Market Worth USD 706.0 Million by 2020 4ECRI Institute's New Robotic Surgery Service Helps Hospitals Brace for Change 2ECRI Institute's New Robotic Surgery Service Helps Hospitals Brace for Change 3Rx Care Management by Proxsys Rx - Transition of Care Technology Helps Prevent Hospital Medication Errors 2
... AirPal ®, a leading innovator and supplier ... the expansion of its line of air-activated transfer pads ... announcement marks the launch of an entire new series ... President AirPal, Inc.  "Among other functions, these exciting new ...
... recently merged with World Wide Relics (OTC Bulletin Board: ... its name to China PharmaHub Corp, is proud to ... Yongkon Pharmacy Co. Ltd., ("Yongkon"), a pharmaceutical company based ... 2600 hospitals in China.  PharmaHub was authorized by Yongkon ...
Cached Medicine Technology:AirPal Expands Line of Air-Activated Transfer Pads to Include Multi-Purpose Patient Positioning Functionality 2China PharmaHub Signs Agreement with Chengdu Yongkon Pharmacy 2China PharmaHub Signs Agreement with Chengdu Yongkon Pharmacy 3
(Date:8/28/2015)... MO (PRWEB) , ... August 28, 2015 , ... ... testosterone lawsuits now consolidated as MDL 2545, Testosterone Replacement Therapy Products ... a cap on the number of custodial files the PSC may receive for ...
(Date:8/28/2015)... ... ... Super-Sod launched their new website this summer. The new user-friendly ... the responsive web design. Website users will now have an improved browsing experience on ... sod, sign-up for the monthly turf-tips email, and find a local Super-Sod store all ...
(Date:8/28/2015)... ... 2015 , ... The Wilson and Juanita Mann Health Center ... a patient’s quality of life through early diagnosis and treatment. The focus is ... HIV/AIDS, STDs, and others. A Women’s, Infants & Children (WIC) clinic also provides ...
(Date:8/27/2015)... ... August 28, 2015 , ... Grace Bay Beach has been recognized ... to an already impressive list of accolades for the Turks and Caicos so far ... beach in the world by TripAdvisor, the world's leading authority on travel. , ...
(Date:8/27/2015)... ... ... Mesa Community College graduate, Andrew Sypher (Mesa), is one of 10 ... and engagement, to receive a Phi Theta Kappa 2015 Hites Transfer Scholarship, to assist ... a $7,500 scholarship to assist in his goal of becoming a foreign diplomat with ...
Breaking Medicine News(10 mins):Health News:National Testosterone Lawyers Provide Testosterone Lawsuit MDL Update 2Health News:National Testosterone Lawyers Provide Testosterone Lawsuit MDL Update 3Health News:National Testosterone Lawyers Provide Testosterone Lawsuit MDL Update 4Health News:Health Clinic Opening and Public Art Unveiling 2Health News:Grace Bay Beach Acknowledged as a Top Caribbean Beach for Weddings 2Health News:Mesa Community College Graduate Andrew Sypher Receives Hites Transfer Scholarship 2Health News:Mesa Community College Graduate Andrew Sypher Receives Hites Transfer Scholarship 3
... show a persistent cellular memory in the brain,s reward ... drug, while their involuntary counterparts had no such memory, ... University of California, San Francisco. , The researchers conclude ... enough to cause long-lasting cellular memories in the brain,s ...
... 30th,Representative Jose Serrano (D-NY) introduced the Community AIDS ... will remove all legal,barriers to States and local ... prevention of diseases directly on syringe exchange.,Syringe exchanges ... intravenous,drug users obtain clean syringes in order to ...
... Toronto Stock Exchange Symbol: CYT, MONTREAL, ... the global leader in cryotherapy products to treat ... CEO of,CryoCath, will present a corporate update at ... will take place Wednesday, August,6th at 8:30 a.m. ...
... athletes gear up to travel to China for the ... respiratory illnesses and dog bites, according to report by ... the Centers for Disease Control and Prevention (CDC) and ... can lead to human rabies. The report finds that ...
... Presented at ICAD 2008 Highlight Significant Improvement in Cognitive Performance ... , ... Chicago, IL (PRWEB) July ... FRX) presented today positive Phase III data of a once-daily ...
... July 30 A minnow has taken on the,giants ... Orgasm Day to,promote the health and sex benefits of ... Ltd, the Orgasm Survey ( http://www.orgasmsurvey.co.uk ),has become a ... But the real story behind the survey has nothing ...
Cached Medicine News:Health News:Cocaine addiction linked to voluntary drug use and cellular memory, UCSF study shows 2Health News:AIDS Action Applauds Introduction of a New Bill Allowing Federal Funds to Support Syringe Exchange Programs 2Health News:AIDS Action Applauds Introduction of a New Bill Allowing Federal Funds to Support Syringe Exchange Programs 3Health News:AIDS Action Applauds Introduction of a New Bill Allowing Federal Funds to Support Syringe Exchange Programs 4Health News:AIDS Action Applauds Introduction of a New Bill Allowing Federal Funds to Support Syringe Exchange Programs 5Health News:AIDS Action Applauds Introduction of a New Bill Allowing Federal Funds to Support Syringe Exchange Programs 6Health News:AIDS Action Applauds Introduction of a New Bill Allowing Federal Funds to Support Syringe Exchange Programs 7Health News:AIDS Action Applauds Introduction of a New Bill Allowing Federal Funds to Support Syringe Exchange Programs 8Health News:AIDS Action Applauds Introduction of a New Bill Allowing Federal Funds to Support Syringe Exchange Programs 9Health News:Respiratory illnesses and dog bites a concern for travelers to China for 2008 Olympics 2Health News:New Data Highlights Positive Results of Namenda (Memantine HCl) Once-Daily Extended-Release Formulation 2Health News:New Data Highlights Positive Results of Namenda (Memantine HCl) Once-Daily Extended-Release Formulation 3Health News:New Data Highlights Positive Results of Namenda (Memantine HCl) Once-Daily Extended-Release Formulation 4Health News:National Orgasm Day 31 July 2008 - Women's Health Campaign Reaches Climax 2
Eyeglass Loupe 3x-5x made with precision optical glass. Ideal for any detail work....
... Specifically designed for computer operators ... may be placed at different heights ... computer screen. Card is printed two ... and green and uses two type ...
Near PT test card/child recog/ playing cards 5 1/2" X 8"....
Near PT test card/4 1/2 to 12 PT in spanish & french /5 1/2" X 8....
Medicine Products: